Poor
Mostly Aligned
Patient Risk:
Low
Summary
The AI-generated claims align with a subset of the labeled information: mechanism (alpha-2 adrenergic action) and hypertension indication. However, there are multiple claims not supported by the label (ADHD indication, pain indications, expiration-related guidance, storage specifics, etc.). No direct label-contradictions were identified, but substantial non-label content was included.
Category Scores
Accurate Statements
Clonidine is a central alpha-2 adrenergic agonist.
Supported by CLINICAL PHARMACOLOGY (p537122)
Clonidine is a central alpha-2 adrenergic agonist that works by stimulating certain receptors in the brain to lower blood pressure and heart rate.
Supported by CLINICAL PHARMACOLOGY (p537122)
Clonidine is often prescribed for hypertension.
Supported by INDICATIONS AND USAGE (p804122)
Unsupported Statements
Clonidine is available in forms including tablets, capsules, and transdermal patches.
Label only confirms transdermal system; tablets/capsules are not described in the provided label content.
Clonidine is often prescribed for ADHD.
ADHD is not listed as an indication in the provided label sections.
Clonidine is often prescribed for certain pain conditions.
Pain indications are not described in the provided label sections.
The expiration date on a medication's packaging is the last date the manufacturer guarantees the product will remain effective and safe to use.
No expiration-date guidance is present in the provided label sections.
This date is typically printed on the packaging in the format of a month and year (e.g., '02/2025').
No packaging date formatting guidance is present in the provided label sections.
The expiration date is not a safety date, but rather a quality date.
No expiration-date guidance is present in the provided label sections.
According to the FDA, medications can still be used after the expiration date, but their effectiveness and safety may be compromised.
No FDA discussion of expiration timing is present in the provided label sections.
The FDA states that most medications are stable for a long time after the expiration date, but it's always best to check with the manufacturer or a pharmacist to confirm.
No FDA discussion of post-expiration stability is present in the provided label sections.
Clonidine is a stable medication that can last for several years after the expiration date.
No expiration-related stability information is present in the provided label sections.
Its potency and effectiveness may decrease over time.
No post-expiration potency guidance is present in the provided label sections.
A study published in the Journal of Pharmaceutical Sciences found that clonidine tablets retained their potency for up to 5 years after the expiration date.
No expiration-study data is present in the provided label sections.
Clonidine should be stored in a cool, dry place, away from direct sunlight and moisture.
Storage guidance in the label is limited to temperature range; 'cool, dry, away from light' is not specified in the provided sections.
The original packaging of clonidine is designed to protect the medication from light, moisture, and air.
No packaging-protection claim is present in the provided label sections.
If the packaging is damaged or compromised, the medication's shelf life may be shortened.
No guidance on packaging integrity affecting shelf life is present in the provided label sections.
Clonidine should be handled carefully to prevent damage or contamination.
No handling/care guidance beyond general storage is present in the provided label sections.
If you have expired clonidine, it's essential to consult with a pharmacist or healthcare professional before using it.
No expiration-related consultation guidance is present in the provided label sections.
They can assess the medication's condition and advise on whether it's safe to use.
No guidance on post-expiration assessment is present in the provided label sections.
If your clonidine has expired, you may be able to obtain a replacement or alternative medication.
No guidance on replacement/alternatives for expired clonidine is present in the provided label sections.
Your healthcare professional or pharmacist can recommend alternative treatments for your condition.
No guidance on non-label alternative treatments is present in the provided label sections.
Clonidine can still be used after the expiration date, but its effectiveness and safety may be compromised.
No expiration-use guidance is present in the provided label sections.
The shelf life of clonidine depends on storage conditions, packaging, and handling.
No shelf-life guidance based on storage/packaging/handling is present in the provided label sections.
Consult with a pharmacist or healthcare professional before using expired clonidine.
No expiration-use guidance is present in the provided label sections.
Contradictions
Low
AI Statement
Clonidine is often prescribed for ADHD.
Label Reference
INDICATIONS AND USAGE (Hypertension) — ADHD not listed
Important Omissions
Administration instructions for the transdermal system (application procedure, site rotation, wear duration, removal).
Importance:
Moderate
Complete safety profile including contraindications, warnings, adverse reactions, drug interactions, and monitoring recommendations.
Importance:
Moderate
Comprehensive storage details beyond temperature (light exposure, moisture control).
Importance:
Moderate
Full dosage/form details for non-transdermal formulations (oral tablets/capsules) if applicable.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Predominant content aligns with label; however, multiple non-label claims could mislead without proper caveats.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Inclusion of ADHD/pain indications and post-expiration/storage-related claims not supported by label.
Suggested Improvement
Retain label-supported statements (mechanism and hypertension indication); remove non-label indications and expiration-related guidance; add label-consistent administration and storage details if discussing approved uses.